Medicare has announced 15 new drugs up for price negotiations, set to begin in the next several months with top drugmakers, ...

On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...

Popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated ...

The negotiated prices of 15 Medicare Part D drugs, which include several blockbusters, will go into effect in 2027.

Ozempic was one of the 15 drugs selected for the 2027 Medicare drug price negotiation program three days before ...

The list of 15 drugs ( up from 10 in 2023) includes four oncology drugs, three drugs targeting diabetes, two focused on COPD, ...

The Centers for Medicare & Medicaid Services (CMS) said Friday that it had selected another 15 drugs for its second round of ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

Announcing the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final health ...

Drugmakers will have until the end of February to decide whether they want to participate in the second round of Medicare ...

Biden's administration announced weight loss drugs Ozempic and Wegovy will be included on Medicare's list of medications ...